Dentsply Sirona INC 8-K filings
NASDAQ
Dentsply Sirona is repositioning its Byte business model to include more in-person dentist oversight, which is expected to result in additional financial impacts in the fourth quarter.
NASDAQ
Dentsply Sirona has appointed Herman V. Cueto as interim CFO while facing a criminal investigation in Germany related to post-merger intercompany loans.
NASDAQ
Dentsply Sirona's third quarter results show a slight increase in net sales but a significant net loss due to goodwill impairment, leading to a revised full-year outlook.
NASDAQ
Dentsply Sirona has temporarily halted sales of its Byte Aligner System and Impression Kits due to a regulatory review, while also reporting preliminary Q3 2024 results including a substantial goodwill impairment.
NASDAQ
Dentsply Sirona's Executive Vice President and Chief Financial Officer, Glenn Coleman, has announced his resignation effective November 7, 2024, to take an executive position at another public company.
NASDAQ
Dentsply Sirona is implementing a restructuring plan to reduce costs and improve operational performance, while also revising its full-year outlook due to lower sales and adjusted EPS.
NASDAQ
Dentsply Sirona's annual meeting saw the election of ten directors, ratification of Deloitte and Touche LLP as auditors, and approval of executive compensation and incentive plans.
NASDAQ
Dentsply Sirona's first quarter 2024 results show a slight sales decrease and mixed performance across segments, while the company maintains its full-year outlook but expects to trend towards the lower end of guidance.
NASDAQ
Dentsply Sirona has dismissed PricewaterhouseCoopers LLP as its independent auditor and appointed Deloitte & Touche LLP, effective March 4, 2024.
NASDAQ
Eric K. Brandt, a long-serving director and former Chairman of Dentsply Sirona, will retire from the Board at the upcoming 2024 annual meeting.
NASDAQ
8-K: Dentsply Sirona Reports Mixed 2023 Results, Provides Cautious 2024 Outlook and Increases Dividend
Dentsply Sirona's full year 2023 results show a slight increase in net sales, a net loss, and a 14% increase in the quarterly dividend, with a flat to modest growth outlook for 2024.